Page last updated: 2024-11-05

carboxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Carboxin is a fungicide with a broad spectrum of activity against various fungal diseases. It is a synthetic compound that acts as a succinate dehydrogenase inhibitor, interfering with the electron transport chain in fungal mitochondria. Carboxin was first synthesized in the 1960s by scientists at the Du Pont Company. Its effectiveness against a wide range of fungal pathogens, including those affecting wheat, barley, rice, and other cereal crops, made it a commercially successful fungicide. However, due to concerns about its potential environmental impact and the emergence of resistant fungal strains, its use has been reduced in recent years. Carboxin is still studied to understand its mode of action, its effects on non-target organisms, and to develop new fungicides with similar efficacy but reduced environmental impact. '

Carboxin: A systemic agricultural fungicide and seed treatment agent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

carboxin : An anilide obtained by formal condensation of the amino group of aniline with the carboxy group of 2-methyl-5,6-dihydro-1,4-oxathiine-3-carboxylic acid. A fungicide for control of bunts and smuts that is normally used as a seed treatment. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID21307
CHEMBL ID1231667
CHEBI ID3405
SCHEMBL ID18392
MeSH IDM0003400

Synonyms (139)

Synonym
AC-12556
BRD-K17610834-001-01-2
chebi:3405 ,
dndi1724944
CHEMBL1231667
2-methyl-n-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide
nsc-263492
5,4-oxathiin-3-carboxanilide
2,4-oxathiin-5-carboxanilide
1, 5,6-dihydro-2-methyl-
wln: t6o ds butj b1 cvmr
1, 5,6-dihydro-2-methyl-n-phenyl-
nsc263492
5-carboxanilido-2,4-oxathiin
1, 2,3-dihydro-5-carboxanilido-6-methyl-
2,4-oxathiin
SDCCGMLS-0037038.P002
cerevax extra
enhance
dmoc (van)
enhance plus
flo pro v seed protectant
5,6-dihydro-2-methyl-3-carboxanilido-1,4-oxathiin [german]
dual murganic rpb
kisvax
vitavax-thiram-lindane
vitavax 30-c
cerevax
germate plus
d735
caswell no. 165a
einecs 226-031-1
carboxine [iso-french]
kemikar
rtv vitavax
d-735
brn 0983249
carboxin [ansi:bsi:iso]
vitavax-200
mist-o-matic murganic
vitavax 34
ccris 5217
nsc 263492
vitaflow
murganic
vitavax-300
epa pesticide chemical code 090201
1,4-oxathiin-3-carboxanilide, 5,6-dihydro-2-methyl-
hsdb 1532
1,4-oxathiin, 2,3-dihydro-5-carboxanilido-6-methyl-
pro-gro
TIMTEC1_001678
smr000069560
MLS000059188
vitavax
6-methyl-n-phenyl-2,3-dihydro-1,4-oxathiine-5-carboxamide
vitavax 75w
carbathiin
karboxyn
vitavax ec 200
vitavax 735d
dmoc
1,4-oxathiin-3-carboxamide, 5,6-dihydro-2-methyl-n-phenyl-
n-phenyl-2-methyl-5,6-dihydrooxathiin-3-carboxamide
fenoxan
v 4x
dcmo
f 735
d 735
vitavax 100
carboxine
vitaflo 250
5234-68-4
carboxin
2,3-dihydro-6-methyl-5-phenylcarbamoyl-1,4-oxathiin
5,6-dihydro-2-methyl-3-carboxanilido-1,4-oxathiin
DB04657
2,3-dihydro-6-methyl-1,4-oxathiin-5-carboxanilide
5-carboxanilido-2,3-dihydro-6-methyl-1,4-oxathiin
2,3-dihydro-5-carboxanilido-6-methyl-1,4-oxathiin
5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxanilide
oxatin
5,6-dihydro-2-methyl-n-phenyl-1,4-oxathiin-3-carboxamide
NCGC00053919-02
NCGC00053919-03
NCGC00053919-04
HMS1538M06
STK838152
AKOS000545990
NCGC00053919-05
NCGC00053919-06
unii-5a8k850hde
5-19-07-00251 (beilstein handbook reference)
5a8k850hde ,
dtxsid0023951 ,
tox21_300706
NCGC00259537-01
NCGC00254614-01
cas-5234-68-4
dtxcid003951
tox21_201988
A829041
6-methyl-n-phenyl-2,3-dihydro-1,4-oxathiin-5-carboxamide
HMS2231N20
carbathiine
FT-0602928
FS-3015
AM20060655
carboxin [hsdb]
carboxin [mi]
carboxin [iso]
S4805
HMS3370C04
AB00083271-01
AB00083271-08
SCHEMBL18392
2-methyl-n-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide #
cambridge id 5373048
W-105831
HMS3604G19
HY-B2064
mfcd00055403
SR-01000388704-1
sr-01000388704
CCG-236658
carboxine, pestanal(r), analytical standard
CS-W019702
5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxanilid; carboxin; cbx
Q2937968
carboxine form ii
O10837
A934631
:2,3-dihydro-5-carboxanilido-6-methyl-4-oxathiin
nsc-816198
nsc816198
EN300-268481
carbathiin;vitavax;kisvax;carboxin
C3482
SY107361

Research Excerpts

Overview

Carboxin is a heterocyclic systemic fungicide, mainly used to prevent and control grain smut and wheat rust. It is a potent inhibitor of the enzyme of certain organisms.

ExcerptReferenceRelevance
"Carboxin is a heterocyclic systemic fungicide, mainly used to prevent and control grain smut and wheat rust. "( Carboxin can induce cardiotoxicity in zebrafish embryos.
Huang, Y; Lu, H; Ma, J; Peng, Y; Wang, Z; Xiong, C; Xu, R; Yan, J; Zhong, K, 2022
)
3.61
"Carboxin is a potent inhibitor of the enzyme of certain organisms."( Carboxin resistance in Paracoccus denitrificans conferred by a mutation in the membrane-anchor domain of succinate:quinone reductase.
Ackrell, BA; Cochran, B; Hederstedt, L; Matsson, M, 1998
)
2.46
"Carboxin is a specific inhibitor of this enzyme from several different organisms."( The carboxin-binding site on Paracoccus denitrificans succinate:quinone reductase identified by mutations.
Hederstedt, L; Matsson, M, 2001
)
1.59

Actions

ExcerptReferenceRelevance
"Carboxin can cause developmental toxicity and cardiotoxicity in zebrafish embryos."( Carboxin can induce cardiotoxicity in zebrafish embryos.
Huang, Y; Lu, H; Ma, J; Peng, Y; Wang, Z; Xiong, C; Xu, R; Yan, J; Zhong, K, 2022
)
2.89

Pharmacokinetics

ExcerptReferenceRelevance
" This unfavorable pharmacokinetic profile of NSC 615985 as well as its pattern of activity against NNRTI-resistant strains of HIV-1 precluded its progression to clinical trial; however, other members of the general chemical class are currently being evaluated by the NCI."( Liquid chromatographic analysis in mouse, dog and human plasma; stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1,4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84).
Chadwick, M; Covey, JM; Ferrala, NF; McComish, MF; Nomeir, AA; Silveira, D, 1998
)
0.3

Compound-Compound Interactions

ExcerptReferenceRelevance
" If UC42 was combined with the [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)]-beta-D-pentofuranosyl (TSAO) derivative of N3-methylthymine (TSAO-m3T), virus breakthrough could be prevented for a much longer time, and at much lower concentrations, than if the compounds were used individually."( Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).
Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Pérez-Pérez, MJ; San-Félix, A; Vélazquez, S, 1995
)
0.29

Bioavailability

ExcerptReferenceRelevance
" The favorable physical characteristics, lack of toxicity, potency and bioavailability of UC 38 may make it a candidate for combination chemotherapy of acquired immune deficiency syndrome."( Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
Bader, JP; Boyd, MR; Brouwer, WG; Buckheit, RW; Currens, MJ; Felauer, EE; Gulakowski, RJ; McMahon, JB; Narayanan, VL; Russell, JD; Schultz, RJ; Shoemaker, RH; Stinson, SF; Vistica, DT, 1996
)
0.29
" NSC 615985 was very poorly absorbed following oral (PO) administration as a suspension in water or in 20% lipid emulsion (Liposyn II)."( Liquid chromatographic analysis in mouse, dog and human plasma; stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1,4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84).
Chadwick, M; Covey, JM; Ferrala, NF; McComish, MF; Nomeir, AA; Silveira, D, 1998
)
0.3

Dosage Studied

ExcerptRelevanceReference
" No parent compound was detected in the urine of NSC 615985 dosed mice."( Liquid chromatographic analysis in mouse, dog and human plasma; stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1,4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84).
Chadwick, M; Covey, JM; Ferrala, NF; McComish, MF; Nomeir, AA; Silveira, D, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitorAn EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor that interferes with the action of succinate dehydrogenase (quinone), EC 1.3.5.1.
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
anilideAny aromatic amide obtained by acylation of aniline.
enamideAn alpha,beta-unsaturated carboxylic acid amide of general formula R(1)R(2)C=CR(3)-C(=O)NR(4)R(5) in which the amide C=O function is conjugated to a C=C double bond at the alpha,beta position.
oxacycleAny organic heterocyclic compound containing at least one ring oxygen atom.
organosulfur heterocyclic compound
anilide fungicideAny amide fungicide whose structure contains an anilide group.
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
succinate to cytochrome bo oxidase electron transfer831
succinate to cytochrome bd oxidase electron transfer723

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency3.98110.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency3.98110.025120.237639.8107AID886
LuciferasePhotinus pyralis (common eastern firefly)Potency39.62460.007215.758889.3584AID1224835; AID588342
pregnane X receptorRattus norvegicus (Norway rat)Potency50.11870.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency9.47550.006038.004119,952.5996AID1159521; AID1159523
TDP1 proteinHomo sapiens (human)Potency26.10110.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency68.58960.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency28.97110.000221.22318,912.5098AID743035; AID743042; AID743053; AID743054; AID743063
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency27.55460.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency65.41890.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency21.05120.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency51.21270.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency36.74750.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency14.80290.000229.305416,493.5996AID1259244; AID1259383; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency7.01510.001024.504861.6448AID588535; AID743212
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency28.18380.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency31.24700.000723.06741,258.9301AID651777; AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency5.87430.001723.839378.1014AID743083
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency29.09290.00419.984825.9290AID504444
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency125.89203.548119.542744.6684AID743266
histone deacetylase 9 isoform 3Homo sapiens (human)Potency26.52850.037617.082361.1927AID1259364; AID1259388
mitogen-activated protein kinase 1Homo sapiens (human)Potency3.16230.039816.784239.8107AID995
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency33.10060.000627.21521,122.0200AID720636; AID743202; AID743219
gemininHomo sapiens (human)Potency1.63600.004611.374133.4983AID624297
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency9.24070.001557.789015,848.9004AID1259244
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency56.23416.309660.2008112.2020AID720707
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency9.24070.001551.739315,848.9004AID1259244
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency63.44660.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency61.62860.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (38)

Processvia Protein(s)Taxonomy
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID1112922Antifungal activity against Fusarium oxysporum assessed as inhibition of mycelium growth at 100 ug/ml2012Molecules (Basel, Switzerland), Nov-30, Volume: 17, Issue:12
Synthesis and antifungal activity of N-(substituted pyridinyl)-1-methyl(phenyl)-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide derivatives.
AID1080684Antifungal activity against Puccinia recondita infected compound pre-treated wheat plant seedlings assessed as wheat leaf rust disease control efficacy at 50 ug/mL under greenhouse conditions2009Journal of agricultural and food chemistry, Jul-08, Volume: 57, Issue:13
Antifungal activity of CHE-23C, a dimeric sesquiterpene from Chloranthus henryi.
AID1112891Fungicidal activity against Oculimacula yallundae assessed as inhibition of germ tube elongation incubated at 19 degC in dark for 48 hr2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112880Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR2 to EC50 for wild type Oculimacula yallundae TriS by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112879Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR2 to EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112923Antifungal activity against Cytospora mandshurica assessed as inhibition of mycelium growth at 100 ug/ml2012Molecules (Basel, Switzerland), Nov-30, Volume: 17, Issue:12
Synthesis and antifungal activity of N-(substituted pyridinyl)-1-methyl(phenyl)-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide derivatives.
AID1080683Antifungal activity against Puccinia recondita infected compound pre-treated wheat plant seedlings assessed as wheat leaf rust disease control efficacy at 20 ug/mL under greenhouse conditions2009Journal of agricultural and food chemistry, Jul-08, Volume: 57, Issue:13
Antifungal activity of CHE-23C, a dimeric sesquiterpene from Chloranthus henryi.
AID1112881Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 to EC50 for wild type Oculimacula yallundae TriS by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112877Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae MDR to EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112878Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae MDR to EC50 for wild type Oculimacula yallundae TriS by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112925Antifungal activity against Fusarium graminearum assessed as inhibition of mycelium growth at 100 ug/ml2012Molecules (Basel, Switzerland), Nov-30, Volume: 17, Issue:12
Synthesis and antifungal activity of N-(substituted pyridinyl)-1-methyl(phenyl)-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide derivatives.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159537qHTS screening for TAG (triacylglycerol) accumulators in algae2017Plant physiology, Aug, Volume: 174, Issue:4
Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (107)

TimeframeStudies, This Drug (%)All Drugs %
pre-199027 (25.23)18.7374
1990's23 (21.50)18.2507
2000's27 (25.23)29.6817
2010's25 (23.36)24.3611
2020's5 (4.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.54 (24.57)
Research Supply Index4.69 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index79.37 (26.88)
Search Engine Supply Index2.43 (0.95)

This Compound (43.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other104 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]